Bladder Small Cell Neuroendocrine Carcinoma
generalA small cell neuroendocrine carcinoma arising from the bladder.
38
Centers
79
Active Trials
—
Cancer Funding
Specific Cancer Types(1)
Top Centers for Bladder Small Cell Neuroendocrine Carcinoma(38)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 71.4 |
| 2 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 71.4 |
| 3 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive High-Volume Research Center | 71.4 |
| 4 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 71.4 |
| 5 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 48.9 |
| 6 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 48.9 |
| 7 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 48.9 |
| 8 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 48.9 |
| 9 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 48.9 |
| 10 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 48.9 |
| 11 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 48.9 |
| 12 | NCI Comprehensive Active Research Program | 48.9 |
| 13 | NCI Comprehensive Active Research Program | 48.9 |
| 14 | NCI Comprehensive Active Research Program | 48.9 |
| 15 | NCI Comprehensive Active Research Program | 48.9 |
| 16 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 48.9 |
| 17 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 48.9 |
| 18 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 48.9 |
| 19 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 48.9 |
| 20 | NCI Clinical Active Research Program | 48.9 |
| 21 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 48.9 |
| 22 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 48.9 |
| 23 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive Active Research Program | 48.9 |
| 24 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 48.9 |
| 25 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 48.9 |
| 26 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 48.9 |
| 27 | University of Illinois Cancer CenterChicago, IL Active Research Program | 48.9 |
| 28 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 48.9 |
| 29 | Cancer Center at IllinoisUrbana, IL Active Research Program | 48.9 |
| 30 | Penn State Cancer InstituteHershey, PA Active Research Program | 48.9 |
| 31 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 48.9 |
| 32 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 48.9 |
| 33 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 48.9 |
| 34 | Active Research Program | 48.9 |
| 35 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 48.9 |
| 36 | Upstate Cancer CenterSyracuse, NY Active Research Program | 48.9 |
| 37 | University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program | 48.9 |
| 38 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 48.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →